Description
While the study demonstrates pyroptosis induction and inflammatory factor release, the downstream effects on the tumor microenvironment, immune cell infiltration, and overall anti-tumor immunity remain unexplored. This knowledge gap limits understanding of the therapeutic potential and optimal implementation of pyroptosis-based GBM immunotherapy.
Gap type: open_question Source paper: EZH2-STAT3 signaling pathway regulates GSDMD-mediated pyroptosis in glioblastoma. (2024, Cell death discovery, PMID:39069522)